Evidence map›Paper›PMID 32251716›Full record

ArticleAutoimmunity reviews2020

What is the role of rheumatologists in the era of COVID-19?

Daniela Marotto, Piercarlo Sarzi-Puttini

Abstract readLetter
In one paragraph

Article in Autoimmunity reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. The radiological findings of COVID-19Turkish journal of medical sciences · 2021
    Review
  3. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Covid-19 and autoimmunity.Autoimmunity reviews · 2020
    Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniela MarottoRheumatology Unit, ATS Sardegna, P. Dettori Hospital, Tempio Pausania, Italy.
Piercarlo Sarzi-PuttiniRheumatology Unit, ASST-Fatebenefratelli L, Sacco University Hospital, University of Milan, Italy. Electronic address: piercarlo.sarziputtini@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Physician's RoleRheumatologistsAgedAged, 80 and overAntibodies, Monoclonal, HumanizedAntimalarialsAzetidinesBetacoronavirusChloroquineComorbidityCoronavirus InfectionsCOVID-19HumansHydroxychloroquineInterleukin-1Middle AgedAntibodies, Monoclonal, HumanizedAntimalarialsAzetidinesbaricitinibChloroquineHydroxychloroquineInterleukin-1PurinesPyrazolessarilumabSulfonamidestocilizumab

Identifiers

PMID32251716
PMCPMC7129715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.